AnewPharma: Clinical Trials

9 trials sponsored by AnewPharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 unknown, 2 suspended. 9 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 19Completed 4, Unknown 3, Suspended 2

Follow AnewPharma: new trials by email

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Absorption, Metabolism and Excretion of [14C]CM082 in Human
[14]CM082 suspension - Advanced Solid Tumor
Phase 1CompletedAnewPharma42021-07-052022-11-14
Bioequivalency Study of CM082 Tablet in Healthy Volunteers
CM082 tablet (test product), CM082 tablet (reference product) - Advanced Malignant Solid Tumors
Phase 1CompletedAnewPharma962020-06-012021-11-26
A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers
CM082 with fed or fasting - Advanced Malignant Solid Tumors
Phase 1CompletedAnewPharma242019-12-192020-05-21
CM082 in Patients With Myopic Choroidal Neovascularization (CNV)
CM082 - Myopic Choroidal Neovascularisation
Phase 1SuspendedAnewPharma962019-12-182021-03-10
Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors
CM082 - Advanced Malignant Solid Tumors
Phase 1UnknownAnewPharma192019-02-262022-11-14
Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer
CM082 plus paclitaxel - Advanced Gastric Cancer
Phase 1UnknownAnewPharma212018-03-152019-02-21
Study of the Combination of CM082 With Everolimus in Patients With mRCC
CM082, Everolimus - Renal Cell Carcinoma Recurrent
Phase 1UnknownAnewPharma182015-09-012018-01-10
Phase 1 Study of CM082 in Patients With wAMD
CM082 tablet - Age-Related Macular Degeneration
Phase 1SuspendedAnewPharma562015-03-012020-01-13
Phase 1 Study of CM082 (X-82) Tablets in Advanced Cancer Patients in China
CM082 Tablet - Advanced Cancer
Phase 1CompletedAnewPharma442013-05-012019-07-05

Conditions studied

Macular Degeneration (1)

Interventions

vorolanib (8)  ·  Everolimus (1)  ·  Paclitaxel (1)

Countries

China (9)

Top investigators

Aiping Zhou, MD (1)  ·  Feng Shao, Ph D (1)  ·  Jin Li, M.D (1)  ·  Jin-Wan Wang, M.D. (1)  ·  Jun Guo, M.D (1)  ·  Ming Zhang, MD (1)  ·  Wei Liu, M.A (1)  ·  Xinan Sheng, M.D (1)  ·  Youxin Chen (1)

Results publications

PMID 37041349